Inclisiran: an addition to the lipid lowering therapies pool. Gives patients & clinicians better opportunity to lower LDL-C to NICE thresholds ⬇️ CVD. Per NICE, those with LDL-C ≥ 2.6 despite statins qualify. No other special initiation / monitoring requirements. See pathway